Zacks Investment Research has initiated the coverage of Onfolio Holdings Inc. ONFO with a “Neutral” recommendation. The report highlights the company’s rapid revenue growth and improving operational ...
Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago. These figures are adjusted ...